C
CytImmune Sciences
Rockville, United States
Founded 1988
About
Developer of gold nanoparticle-based cancer therapeutics
Company Details
- Type
- commercial
- Employees
- 10-50
- Funding
- $100M+
Key Products
- Aurimune
- CYT-6091
Developer of gold nanoparticle-based cancer therapeutics